Other medications commonly used in this setting include alphaglucosidase inhibitors, DPP4 inhibitors, GLP-1 receptor agonists, somatostatin analogues and diazoxide
DOI: 10.1016/j.ajcnut.2025.02.012 Bartimoccia, S., Cammisotto, V., Nocella, C., et al
The clinical model provides medium-level support with some high-support features
While the exact mechanisms by which tirzepatide exerts its effects are not fully understood, it is believed to work through multiple complementary pathways to improve glycemic control and promote weight loss
While the medications begin working right away to influence hunger hormones, healthy and sustainable weight loss occurs gradually
Among these treatments (Blanco et al., 2011